Annual Accounts Receivable
$333.70 K
+$2500.00+0.75%
December 31, 2023
Summary
- As of February 23, 2025, POAI annual accounts receivable is $333.70 thousand, with the most recent change of +$2500.00 (+0.75%) on December 31, 2023.
- During the last 3 years, POAI annual accounts receivable has risen by +$76.80 thousand (+29.89%).
- POAI annual accounts receivable is now -5.79% below its all-time high of $354.20 thousand, reached on December 31, 2021.
Performance
POAI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$463.80 K
+$76.80 K+19.84%
September 30, 2024
Summary
- As of February 23, 2025, POAI quarterly accounts receivable is $463.80 thousand, with the most recent change of +$76.80 thousand (+19.84%) on September 30, 2024.
- Over the past year, POAI quarterly accounts receivable has stayed the same.
- POAI quarterly accounts receivable is now -14.87% below its all-time high of $544.80 thousand, reached on September 30, 2023.
Performance
POAI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
POAI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | 0.0% |
| 3 y3 years | +29.9% | +7.7% |
| 5 y5 years | +43.5% | +7.7% |
POAI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +0.8% | -14.9% | +75.0% |
| 5 y | 5-year | -5.8% | +29.9% | -14.9% | +136.0% |
| alltime | all time | -5.8% | -100.0% | -14.9% | -100.0% |
Predictive Oncology Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $463.80 K(+19.8%) |
| Jun 2024 | - | $387.00 K(-24.0%) |
| Mar 2024 | - | $509.40 K(+52.7%) |
| Dec 2023 | $333.70 K(+0.8%) | $333.70 K(-38.7%) |
| Sep 2023 | - | $544.80 K(+26.5%) |
| Jun 2023 | - | $430.80 K(+52.3%) |
| Mar 2023 | - | $282.80 K(-14.6%) |
| Dec 2022 | $331.20 K(-6.5%) | $331.20 K(+2.0%) |
| Sep 2022 | - | $324.70 K(-3.5%) |
| Jun 2022 | - | $336.40 K(+26.9%) |
| Mar 2022 | - | $265.00 K(-25.2%) |
| Dec 2021 | $354.20 K(+37.9%) | $354.20 K(+28.7%) |
| Sep 2021 | - | $275.20 K(+40.1%) |
| Jun 2021 | - | $196.50 K(-25.8%) |
| Mar 2021 | - | $264.90 K(+3.1%) |
| Dec 2020 | $256.90 K(-13.5%) | $256.90 K(-49.5%) |
| Sep 2020 | - | $508.30 K(+86.5%) |
| Jun 2020 | - | $272.50 K(+1.0%) |
| Mar 2020 | - | $269.80 K(-9.2%) |
| Dec 2019 | $297.10 K(+27.7%) | $297.10 K(-20.2%) |
| Sep 2019 | - | $372.10 K(+24.4%) |
| Jun 2019 | - | $299.00 K(+72.4%) |
| Mar 2019 | - | $173.40 K(-25.5%) |
| Dec 2018 | $232.60 K(+69.2%) | $232.60 K(-2.5%) |
| Sep 2018 | - | $238.60 K(-24.3%) |
| Jun 2018 | - | $315.30 K(+30.4%) |
| Mar 2018 | - | $241.80 K(+75.9%) |
| Dec 2017 | $137.50 K | $137.50 K(+49.9%) |
| Sep 2017 | - | $91.70 K(+103.8%) |
| Jun 2017 | - | $45.00 K(-34.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $68.50 K(+76.1%) |
| Dec 2016 | $38.90 K(+1.6%) | $38.90 K(-13.6%) |
| Sep 2016 | - | $45.00 K(+90.7%) |
| Jun 2016 | - | $23.60 K(-55.3%) |
| Mar 2016 | - | $52.80 K(+37.9%) |
| Dec 2015 | $38.30 K(-33.4%) | $38.30 K(+169.7%) |
| Sep 2015 | - | $14.20 K(-10.7%) |
| Jun 2015 | - | $15.90 K(-82.3%) |
| Mar 2015 | - | $90.00 K(+56.5%) |
| Dec 2014 | $57.50 K(-40.8%) | $57.50 K(-75.9%) |
| Sep 2014 | - | $238.60 K(+59.5%) |
| Jun 2014 | - | $149.60 K(+134.1%) |
| Mar 2014 | - | $63.90 K(-34.3%) |
| Dec 2013 | $97.20 K(+144.8%) | $97.20 K(+16.8%) |
| Sep 2013 | - | $83.20 K(-18.4%) |
| Jun 2013 | - | $101.90 K(+5.4%) |
| Mar 2013 | - | $96.70 K(+143.6%) |
| Dec 2012 | $39.70 K(-21.1%) | $39.70 K(-0.3%) |
| Sep 2012 | - | $39.80 K(+24.0%) |
| Jun 2012 | - | $32.10 K(+68.1%) |
| Mar 2012 | - | $19.10 K(-62.0%) |
| Dec 2011 | $50.30 K(>+9900.0%) | $50.30 K(+160.6%) |
| Sep 2011 | - | $19.30 K(+2312.5%) |
| Jun 2011 | - | $800.00(>+9900.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $15.70 K(>+9900.0%) | $15.70 K(0.0%) |
| Sep 2009 | - | $15.70 K(>+9900.0%) |
| Dec 2008 | $0.00 | $0.00 |
FAQ
- What is Predictive Oncology annual accounts receivable?
- What is the all time high annual accounts receivable for Predictive Oncology?
- What is Predictive Oncology annual accounts receivable year-on-year change?
- What is Predictive Oncology quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Predictive Oncology?
- What is Predictive Oncology quarterly accounts receivable year-on-year change?
What is Predictive Oncology annual accounts receivable?
The current annual accounts receivable of POAI is $333.70 K
What is the all time high annual accounts receivable for Predictive Oncology?
Predictive Oncology all-time high annual accounts receivable is $354.20 K
What is Predictive Oncology annual accounts receivable year-on-year change?
Over the past year, POAI annual accounts receivable has changed by +$2500.00 (+0.75%)
What is Predictive Oncology quarterly accounts receivable?
The current quarterly accounts receivable of POAI is $463.80 K
What is the all time high quarterly accounts receivable for Predictive Oncology?
Predictive Oncology all-time high quarterly accounts receivable is $544.80 K
What is Predictive Oncology quarterly accounts receivable year-on-year change?
Over the past year, POAI quarterly accounts receivable has changed by $0.00 (0.00%)